In fact, even in genome-wide analyses of common epilepsies, SCN1A is identified as a key risk gene (Anney et al., 2014) suggesting that the phenotypes associated with SCN1A variants extend far beyond the patients with more severe childhood onset epilepsies in whom a clinical diagnosis of SCN1A variants is now made on routine clinical testing. This evidence concerns the gene SCN1A and epilepsy.